Press Releases Items Per Page 102550 News Category FinancialGeneral Year None202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Therapeutics Issues Statement Confirming That It Does Not Hold Any Cash Deposits or Securities at Silicon Valley Bank Mar 11, 2023 Nektar Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results Feb 28, 2023 Nektar Therapeutics Announces Phase 2 Topline Data for Rezpegaldesleukin in Patients with Systemic Lupus Erythematosus Feb 23, 2023 Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA Jan 04, 2023 Nektar Announces Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting Dec 12, 2022 Nektar Therapeutics to Host Investor & Analyst Event on December 12th Dec 05, 2022 Nektar Therapeutics Presents Preclinical Data from Novel PEGylated Interferon Gamma Program, NKTR-288, at the Society for Immunotherapy of Cancer (SITC) Annual Meeting Nov 10, 2022 Nektar and Collaborators Announce Publication in Blood Advances of Preclinical Data Demonstrating NKTR-255, a Novel Polymer-conjugated Human IL-15, Improves Efficacy of CD19-targeted CAR-T Cell Immunotherapy Nov 09, 2022 Nektar Therapeutics Reports Third Quarter 2022 Financial Results Nov 03, 2022 Nektar to Announce Financial Results for the Third Quarter 2022 on Thursday, November 3, 2022, After Close of U.S.-Based Financial Markets Oct 25, 2022 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »